Home LiteratureArticle Details
PMID: 9151833 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

In vitro assembly of virus-like particles with Rous sarcoma virus Gag deletion mutants: identification of the p10 domain as a morphological determinant in the formation of spherical particles.

Journal of virology ·Vol. 71 ·No. 6 ·1997-06-00 ·Pages 4425-35

Campbell S, Vogt VM

Abstract

Retroviruses are unusual in that expression of a single protein, Gag, leads to budding of virus-like particles into the extracellular space. We have developed conditions under which virus-like particles are formed spontaneously in vitro from fragments of Rous sarcoma virus (RSV) Gag protein purified after expression in Escherichia coli. The CA-NC fragment of Gag was shown previously to assemble into hollow cylinders (S. Campbell and V. M. Vogt, J. Virol. 69:6487-6497, 1995). We have now extended these studies to larger Gag proteins. In every case examined, assembly into regular structures required RNA. A nearly full-length Gag missing only the C-terminal PR domain, as well as similar proteins missing in addition the N-terminal half of MA, the C-terminal half of MA, the entire MA sequence, or the entire p2 sequence, all assembled into spherical particles resembling RSV in size. By contrast, proteins missing p10 assembled into cylindrical particles like those formed by CA-NC alone. Thin section electron microscopy showed that each of these Gag proteins formed in the expressing E. coli cells particles similar in shape to those seen in vitro. We conclude from these results that neither the sequences required for membrane binding in vivo, near the N terminus of Gag, nor the sequences required for a late step in budding, in the p2 portion of Gag, are essential for formation of virus-like particles in this system. Furthermore, we postulate the existence of a shape-determining sequence in p10, which provides or facilitates interactions required for the growing particle to be constrained to a spherical shape.

MeSH Terms
Avian Sarcoma Viruses/chemistry,growth & development,ultrastructure Gene Products, gag/physiology Macromolecular Substances Microscopy, Electron Morphogenesis RNA, Viral/metabolism Recombinant Proteins Ribonucleoproteins/metabolism Virion/ultrastructure
Chemicals
Gene Products, gag Macromolecular Substances RNA, Viral Recombinant Proteins Ribonucleoproteins
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Campbell S
Section of Biochemistry, Molecular and Cell Biology, Cornell University, Ithaca, New York 14853, USA.
Vogt V M
References (59)
59 references, click to expand
  1. Further evidence of icosahedral symmetry in human and simian immunodeficiency virus.
    AIDS Res Hum Retroviruses. 1993 Oct;9(10):929-38 PMID: 8280478
  2. Characterization of a small (25-kilodalton) derivative of the Rous sarcoma virus Gag protein competent for particle release.
    J Virol. 1993 Sep;67(9):5550-61 PMID: 8394460
  3. Identification of human immunodeficiency virus type 1 Gag protein domains essential to membrane binding and particle assembly.
    J Virol. 1994 May;68(5):3232-42 PMID: 8151785
  4. Efficiency and selectivity of RNA packaging by Rous sarcoma virus Gag deletion mutants.
    J Virol. 1994 Sep;68(9):5969-81 PMID: 8057473
  5. Evidence that a central domain of nucleocapsid protein is required for RNA packaging in murine leukemia virus.
    J Virol. 1994 Sep;68(9):6124-9 PMID: 8057495
  6. An assembly domain of the Rous sarcoma virus Gag protein required late in budding.
    J Virol. 1994 Oct;68(10):6605-18 PMID: 8083996
  7. Expression of tobacco mosaic virus coat protein and assembly of pseudovirus particles in Escherichia coli.
    Proc Natl Acad Sci U S A. 1994 Sep 13;91(19):9067-71 PMID: 8090770
  8. Comparative morphology of Gag protein structures produced by mutants of the gag gene of human immunodeficiency virus type 1.
    J Gen Virol. 1994 Nov;75 ( Pt 11):2985-97 PMID: 7964608
  9. Efficient in vivo and in vitro assembly of retroviral capsids from Gag precursor proteins expressed in bacteria.
    J Virol. 1995 Feb;69(2):1093-8 PMID: 7815488
  10. Mutations in the N-terminal region of human immunodeficiency virus type 1 matrix protein block intracellular transport of the Gag precursor.
    J Virol. 1993 Nov;67(11):6387-94 PMID: 8411340
  11. Functional chimeras of the Rous sarcoma virus and human immunodeficiency virus gag proteins.
    J Virol. 1993 Nov;67(11):6487-98 PMID: 8411352
  12. Capsid assembly and involved function analysis of twelve core protein mutants of duck hepatitis B virus.
    J Virol. 1994 Jan;68(1):338-45 PMID: 8254745
  13. Fullerene-like organization of HIV gag-protein shell in virus-like particles produced by recombinant baculovirus.
    Virology. 1994 Jan;198(1):288-96 PMID: 8259664
  14. Positionally independent and exchangeable late budding functions of the Rous sarcoma virus and human immunodeficiency virus Gag proteins.
    J Virol. 1995 Sep;69(9):5455-60 PMID: 7636991
  15. Nucleocapsid protein effects on the specificity of retrovirus RNA encapsidation.
    J Virol. 1995 Sep;69(9):5716-22 PMID: 7637017
  16. Retroviral nucleocapsid domains mediate the specific recognition of genomic viral RNAs by chimeric Gag polyproteins during RNA packaging in vivo.
    J Virol. 1995 Oct;69(10):6445-56 PMID: 7666546
  17. Self-assembly in vitro of purified CA-NC proteins from Rous sarcoma virus and human immunodeficiency virus type 1.
    J Virol. 1995 Oct;69(10):6487-97 PMID: 7666550
  18. The packaging phenotype of the SE21Q1b provirus is related to high proviral expression and not trans-acting factors.
    J Virol. 1995 Nov;69(11):7319-23 PMID: 7474162
  19. Complete inhibition of human immunodeficiency virus Gag myristoylation is necessary for inhibition of particle budding.
    J Biol Chem. 1996 Feb 2;271(5):2868-73 PMID: 8576268
  20. A large region within the Rous sarcoma virus matrix protein is dispensable for budding and infectivity.
    J Virol. 1996 Apr;70(4):2269-76 PMID: 8642653
  21. Analysis of Rous sarcoma virus Gag protein by mass spectrometry indicates trimming by host exopeptidase.
    J Virol. 1996 May;70(5):3313-8 PMID: 8627817
  22. Synthesis and assembly of retrovirus Gag precursors into immature capsids in vitro.
    J Virol. 1996 Jun;70(6):3706-15 PMID: 8648705
  23. Human immunodeficiency virus type 1 capsid formation in reticulocyte lysates.
    J Virol. 1996 Nov;70(11):8187-94 PMID: 8892951
  24. Structure of a murine leukemia virus after disruption with tween-ether and comparison with two myxoviruses.
    Virology. 1966 Apr;28(4):713-28 PMID: 5938890
  25. Helical nucleocapsid structure of the oncogenic ribonucleic acid viruses (oncornaviruses).
    J Virol. 1971 Oct;8(4):564-72 PMID: 4108573
  26. Properties of mouse leukemia viruses. 3. Electron microscopic appearance as revealed after conventional preparation techniques as well as freeze-drying and freeze-etching.
    Virology. 1972 Aug;49(2):345-58 PMID: 4115401
  27. Deficiency of 60 to 70S RNA in murine leukemia virus particles assembled in cells treated with actinomycin D.
    J Virol. 1974 Jul;14(1):152-61 PMID: 4134468
  28. Rauscher leukemia virus populations enriched for "immature" virions contain increased amounts of P70, the gag gene product.
    J Virol. 1978 Jan;25(1):416-21 PMID: 621782
  29. An avian oncovirus mutant (SE 21Q1b) deficient in genomic RNA: biological and biochemical characterization.
    Cell. 1978 Dec;15(4):1371-81 PMID: 83199
  30. Nucleotide sequence of Rous sarcoma virus.
    Cell. 1983 Mar;32(3):853-69 PMID: 6299578
  31. Purification and properties of a fifth major viral gag protein from avian sarcoma and leukemia viruses.
    J Virol. 1983 Feb;45(2):648-58 PMID: 6300427
  32. Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes.
    J Mol Biol. 1986 May 5;189(1):113-30 PMID: 3537305
  33. Myristylation is required for intracellular transport but not for assembly of D-type retrovirus capsids.
    J Virol. 1987 Apr;61(4):1045-53 PMID: 3493352
  34. Electron microscopy of human immunodeficiency virus.
    J Gen Virol. 1988 Oct;69 ( Pt 10):2455-69 PMID: 2459300
  35. Point mutants of Moloney murine leukemia virus that fail to package viral RNA: evidence for specific RNA recognition by a "zinc finger-like" protein sequence.
    Proc Natl Acad Sci U S A. 1988 Nov;85(22):8420-4 PMID: 3141927
  36. The intracisternal A-particle gene family: structure and functional aspects.
    Adv Cancer Res. 1988;51:183-276 PMID: 3146900
  37. Unmyristylated Moloney murine leukemia virus Pr65gag is excluded from virus assembly and maturation events.
    J Virol. 1989 May;63(5):2370-3 PMID: 2649693
  38. Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells.
    Cell. 1989 Oct 6;59(1):103-12 PMID: 2676191
  39. The GAG precursor of simian immunodeficiency virus assembles into virus-like particles.
    EMBO J. 1989 Sep;8(9):2653-60 PMID: 2684654
  40. RNA-binding properties of the matrix protein (p19gag) of avian sarcoma and leukemia viruses.
    J Virol. 1990 Feb;64(2):847-55 PMID: 2153248
  41. Noninfectious human immunodeficiency virus type 1 mutants deficient in genomic RNA.
    J Virol. 1990 Jul;64(7):3207-11 PMID: 2191147
  42. Use of T7 RNA polymerase to direct expression of cloned genes.
    Methods Enzymol. 1990;185:60-89 PMID: 2199796
  43. Incorporation of chimeric gag protein into retroviral particles.
    J Virol. 1990 Sep;64(9):4169-79 PMID: 2166812
  44. Retroviral RNA packaging: sequence requirements and implications.
    Curr Top Microbiol Immunol. 1990;157:125-52 PMID: 2394131
  45. Properties of avian retrovirus particles defective in viral protease.
    J Virol. 1990 Oct;64(10):5076-92 PMID: 1697912
  46. A single amino acid substitution within the matrix protein of a type D retrovirus converts its morphogenesis to that of a type C retrovirus.
    Cell. 1990 Oct 5;63(1):77-86 PMID: 2170021
  47. Characterization of virus-like particles produced by a recombinant baculovirus containing the gag gene of the bovine immunodeficiency-like virus.
    Virology. 1990 Oct;178(2):435-51 PMID: 1699349
  48. Suppression of retroviral MA deletions by the amino-terminal membrane-binding domain of p60src.
    J Virol. 1991 Jul;65(7):3804-12 PMID: 1710290
  49. Functional domains of HIV-1 gag-polyprotein expressed in baculovirus-infected cells.
    Virology. 1991 Sep;184(1):417-22 PMID: 1871977
  50. Form, function, and use of retroviral gag proteins.
    AIDS. 1991 Jun;5(6):639-54 PMID: 1883539
  51. trans-acting viral protease is necessary and sufficient for activation of avian leukosis virus reverse transcriptase.
    J Virol. 1991 Nov;65(11):6218-31 PMID: 1717719
  52. A quick procedure for purification of functional recombinant proteins over-expressed in E.coli.
    Nucleic Acids Res. 1991 Dec 11;19(23):6650 PMID: 1754408
  53. Specificity of Rous sarcoma virus nucleocapsid protein in genomic RNA packaging.
    J Virol. 1992 Aug;66(8):4662-70 PMID: 1378506
  54. Purification of immature cores of mouse mammary tumor virus and immunolocalization of protein domains.
    J Virol. 1992 Sep;66(9):5615-20 PMID: 1380097
  55. The nonmyristylated Pr160gag-pol polyprotein of human immunodeficiency virus type 1 interacts with Pr55gag and is incorporated into viruslike particles.
    J Virol. 1992 Nov;66(11):6304-13 PMID: 1383561
  56. Analysis of deletions and thermosensitive mutations in Rous sarcoma virus gag protein p10.
    J Virol. 1993 Jul;67(7):3826-34 PMID: 7685400
  57. The two zinc fingers in the human immunodeficiency virus type 1 nucleocapsid protein are not functionally equivalent.
    J Virol. 1993 Jul;67(7):4027-36 PMID: 8510214
  58. A large deletion in the matrix domain of the human immunodeficiency virus gag gene redirects virus particle assembly from the plasma membrane to the endoplasmic reticulum.
    J Virol. 1993 Aug;67(8):4972-80 PMID: 8331736
  59. Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids.
    J Virol. 1994 Apr;68(4):2556-69 PMID: 8139035
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
1997-06-00
Pages
4425-35
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC191661
Subset
IM
Grants
NCI NIH HHS · CA-20081 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]